Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXD6WE
|
||||
| Drug Name |
(3-(5-amino-1-(pyridin-2-yl)-1H-1,2,4-triazol-3-ylamino)phenyl)(morpholino)methanone
|
||||
| Synonyms |
CHEMBL1835864
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C18H19N7O2
|
||||
| Canonical SMILES |
Nc1nc(Nc2cccc(c2)C(=O)N3CCOCC3)nn1c4ccccn4
|
||||
| InChI |
InChI=1S/C18H19N7O2/c19-17-22-18(23-25(17)15-6-1-2-7-20-15)21-14-5-3-4-13(12-14)16(26)24-8-10-27-11-9-24/h1-7,12H,8-11H2,(H3,19,21,22,23)
|
||||
| InChIKey |
VBBRNWQCPHQDID-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | FL cytokine receptor | Target Info | [1587926] | ||
| Mast/stem cell growth factor receptor | Target Info | [1587926] | |||
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Hematopoietic cell lineage | |||||
| Pathways in cancer | |||||
| Transcriptional misregulation in cancer | |||||
| Acute myeloid leukemia | |||||
| Central carbon metabolism in cancerhsa04014:Ras signaling pathway | |||||
| Rap1 signaling pathway | |||||
| Endocytosis | |||||
| PI3K-Akt signaling pathway | |||||
| Melanogenesis | |||||
| Central carbon metabolism in cancer | |||||
| Pathway Interaction Database | C-MYB transcription factor network | ||||
| Signaling events mediated by Stem cell factor receptor (c-Kit) | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.